| Record ID | marc_loc_2016/BooksAll.2016.part18.utf8:16983844:1275 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part18.utf8:16983844:1275?format=raw |
LEADER: 01275cam a2200301 a 4500
001 87032308
003 DLC
005 19980922110809.0
008 871123s1987 au a b 101 0 eng c
010 $a 87032308 //r98
020 $a0387820094 (U.S.)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC382$b.M365 1987
060 $aW1 JO781A v. 25$aWL 359 M296 1987
082 00 $a616.8/33061$219
245 00 $aMAO-B-inhibitor selegiline (R-(-)-deprenyl) :$ba new therapeutic concept in the treatment of Parkinson's disease : proceedings of the international symposium in Berlin, January 23-25, 1987 /$cP. Riederer and H. Przuntek (eds.).
260 0 $aWien ;$aNew York :$bSpringer-Verlag,$cc1987.
300 $ax, 197 p. :$bill. ;$c23 cm.
440 0 $aJournal of neural transmission.$pSupplementum ;$v25
504 $aIncludes bibliographies and index.
650 0 $aSelegiline$xTesting$xCongresses.
650 0 $aParkinson's disease$xChemotherapy$xCongresses.
650 0 $aAntiparkinsonian agents$xTesting$xCongresses.
650 2 $aMonoamine Oxidase Inhibitors$xcongresses.
650 2 $aParkinson Disease$xdrug therapy$xcongresses.
650 2 $aPhenethylamines$xtherapeutic use$xcongresses.
700 10 $aRiederer, P.$q(Peter)
700 10 $aPrzuntek, H.$q(Horst),$d1938-